DETERMINATION OF FLUCONAZOLE IN HUMAN SERUM BY SOLID-PHASE EXTRACTION AND REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引:54
作者
INAGAKI, K
TAKAGI, J
LOR, E
OKAMOTO, MP
GILL, MA
机构
[1] UNIV SO CALIF, SCH PHARM, LOS ANGELES, CA 90033 USA
[2] MEIJO UNIV, FAC PHARM, NAGOYA, AICHI 468, JAPAN
[3] KENNETH NORRIS JR CANC HOSP & RES INST, LOS ANGELES, CA USA
[4] SAN FRANCISCO GEN HOSP, AIDS INPATIENT UNIT, SAN FRANCISCO, CA 94110 USA
关键词
FLUCONAZOLE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID-PHASE COLUMN; HUMAN; ANTIFUNGAL AGENT;
D O I
10.1097/00007691-199208000-00008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A simple, rapid, and accurate reversed-phase octadecylsilyl high-performance liquid chromatographic method using solid-phase column extraction is described for measuring fluconazole in human serum. The column eluent was monitored by ultraviolet absorption at 210 nm. Fluconazole was extracted from diluted serum by adsorption on a small Bond-Elut C18 cartridge after the addition of UK48,134 as the internal standard and recovered by elution with methanol. The methanol was then evaporated to dryness and the residue reconstituted in 200-mu-l of mobile phase and filtered prior to injecting an aliquot (50-mu-l) onto an Adsorbosphere C18 column (4.6 x 250 mm, 5-mu-m particle size), using a mobile phase of 25 mM tris(hydroxymethyl)aminomethane-phosphate buffer (pH 7.0):acetonitrile (75:25, vol/vol). The retention times were 6.6 min for fluconazole and 9.0 min for the internal standard. The assay was precise, with inter- and intraassay coefficients of variation of less-than-or-equal-to 2.9% and less-than-or-equal-to 2.1%, respectively, and with good linearity (r = 1.000) in the range of 0.1 to 25-mu-g/ml. The duration of each analysis was 15 min and the minimum detectable serum concentration was 0.1-mu-g/ml.
引用
收藏
页码:306 / 311
页数:6
相关论文
共 18 条
  • [1] ADAMOVICS JA, 1990, CHROMATOGRAPHIC SCI, V49, P167
  • [2] BRAMMER KW, 1990, REV INFECT DIS, V12, pS318
  • [3] CHEN X, 1990, J CHROMATOGR, V259, P161
  • [4] DETERMINATION OF FLUCONAZOLE IN BIOLOGICAL-FLUIDS BY CAPILLARY COLUMN GAS-CHROMATOGRAPHY WITH A NITROGEN DETECTOR
    DEBRUYNE, D
    RYCKELYNCK, JP
    BIGOT, MC
    MOULIN, M
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (06) : 534 - 535
  • [5] FLUCONAZOLE PENETRATION INTO CEREBROSPINAL-FLUID IN HUMANS
    FOULDS, G
    BRENNAN, DR
    WAJSZCZUK, C
    CATANZARO, A
    GARG, DC
    KNOPF, W
    RINALDI, M
    WEIDLER, DJ
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (04) : 363 - 366
  • [6] FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES
    GRANT, SM
    CLISSOLD, SP
    [J]. DRUGS, 1990, 39 (06) : 877 - 916
  • [7] HEYKANTS J, 1990, BRIT J CLIN PRACT, V44, P50
  • [8] RAPID-DETERMINATION OF SERUM LEVELS OF A NEW ANTIFUNGAL AGENT, FLUCONAZOLE, BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    HOSOTSUBO, KK
    HOSOTSUBO, H
    NISHIJIMA, MK
    OKADA, T
    TAENAKA, N
    YOSHIYA, I
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (01): : 223 - 228
  • [9] COMPARISON OF THE INVITRO AND INVIVO ACTIVITY OF THE BIS-TRIAZOLE DERIVATIVE UK-49,858 WITH THAT OF AMPHOTERICIN-B AGAINST HISTOPLASMA-CAPSULATUM
    KOBAYASHI, GS
    TRAVIS, S
    MEDOFF, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) : 660 - 662
  • [10] KOWALSKY SF, 1991, CLIN PHARMACY, V10, P179